Iterative Scopes
About Iterative Scopes
Iterative Scopes, now operating as Iterative Health, is an AI-driven healthcare technology company dedicated to transforming gastroenterology care. The company leverages advanced computer vision and machine learning algorithms to enhance diagnostic accuracy and streamline clinical workflows for physicians. Their core offerings include AI-powered endoscopic scoring systems designed to provide consistent, accurate, and individualized disease assessments.
For gastroenterologists, Iterative Scopes’ technology aims to improve the detection of abnormalities during procedures like endoscopies and colonoscopies, such as automated polyp detection for colorectal cancer screening. Additionally, their solutions standardize disease severity scoring for inflammatory bowel disease (IBD), which is crucial for optimizing patient management and accelerating clinical research. By integrating these AI tools, Iterative Scopes seeks to augment physician decision-making, reduce variability in interpretation, and ultimately improve patient outcomes by facilitating faster access to novel therapeutics through more efficient clinical trials.
Focus Areas
Business Intelligence
| Key Investors | Insight Partners, Clearlake Capital Group, Obvious Ventures, Johnson & Johnson Innovation – JJDC Inc., Eli Lilly and Co., Breyer Capital, 7wire Ventures, Addition, Bessemer Venture Partners, Curie.Bio, Lightbank, Operator Partners, Wavemaker Partners, Tau Ventures, p5hv, Frederic Kerrest, Seae Ventures, Micron Ventures, Time BioVentures, Valor Capital Group, Wavemaker 360, Nat Turner, Zach Weinberg |
| Partnerships | Provation, Eli Lilly and Company, Johnson & Johnson (Janssen Research & Development), One GI, GI Alliance, Gastro Health, US Heart & Vascular |
| Acquisitions | Clinical Research Strategy Group, Precision Research |
| Technology | AI-driven, computer vision, machine learning software, proprietary computational tools, AI-powered endoscopic scoring systems, cloud-native (implied) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Iterative Scopes (now Iterative Health) offers tools to significantly enhance diagnostic accuracy and consistency in gastroenterology. Leveraging their AI-assisted polyp detection device, SKOUTu2122, during colonoscopies can lead to improved adenoma detection rates and better patient outcomes in colorectal cancer screening, without increasing procedure time. Their standardized endoscopic scoring systems provide more objective and consistent assessments of GI diseases, particularly IBD, which can refine treatment decisions and patient management. For those involved in clinical research, their AI-driven recruitment services streamline patient identification and accelerate enrollment in IBD clinical trials, offering access to potentially life-changing new therapies. The technology acts as a powerful complement to physician expertise, enhancing pattern recognition and reducing variability in endoscopic interpretation.
Iterative Scopes actively collaborates with major pharmaceutical companies such as Pfizer, Janssen, and Eli Lilly to advance clinical trials and refine disease scoring algorithms. They maintain an exclusive partnership with Provation for the distribution of SKOUTu2122 and the integration of AI-based solutions into GI documentation software. Furthermore, strategic alliances with large gastroenterology management services organizations like One GIu00ae and Gastro Health aim to democratize access to their AI-based technology and standardize GI care across diverse clinical practices.
What the Web Says
Iterative Scopes (also known as Iterative Health) is a company focused on transforming gastroenterology care and accelerating clinical research using AI. Their product, SKOUT, is an AI-assisted polyp detection device that has received FDA clearance and aims to improve the detection of pre-cancerous lesions during colonoscopies. The company is generally viewed as mission-driven with a focus on making a significant impact in healthcare. As an employer, it's described as a fast-growing startup with a dynamic environment.
Overall: MixedStrengths
- Mission-driven work with a tangible impact on patient care.
- Competitive compensation and benefits.
- Opportunity to be part of building and making an impact in a growing company.
- Team composed of dynamic and engaging colleagues.
- Product (SKOUT) has shown to significantly improve adenoma detection during colonoscopies.
- Focus on people-first workplace culture and strong teamwork.
Limitations
- Fast-moving operating rhythms with shifting priorities can lead to change fatigue and being overwhelmed.
- Heavy workloads and intensity are noted as recurring realities.
- Some references to layoff anxiety and job insecurity as part of a growth company.
- One review mentioned a toxic workplace created by amateurs in 2022.
- A Reddit post raised concerns about a potential 'quid pro quo' offer to use the company's product, including legal fee reimbursement if caught, questioning its legality.
- Limited reviews available on platforms like G2 and Capterra specifically for Iterative Scopes' products, making it difficult to gather widespread product-specific feedback.
Based on reviews from: Indeed.com, Forbes, G2.com, Fierce Biotech, Reddit, Built In
Last updated: 2026-07-18
Videos
News, demos, and interviews about Iterative Scopes.
Videos load interactively. If none appear, search YouTube for Iterative Scopes →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Iterative Scopes.
Related Companies
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]
Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]
The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]
Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]
Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]